D-0064-2021 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0064-2021 was initiated by Teligent Pharma, Inc. on Sep 28, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity. The recall status is terminated (terminated Aug 22, 2022). Affected quantity: 36,790 tubes.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2020
Initiation Date
Sep 28, 2020
Termination Date
Aug 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36,790 tubes

Product description

Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15, b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310

Reason for recall

Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.

Distribution pattern

United States Nationwide

Code information

Lot#: a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0064-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0064-2021. Report a data issue: hello@regdatalab.com.